INFLUENCE OF CYP3A4, CYP3A5, POR AND ABCB1 GENES ON TACROLIMUS RESPONSE IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Naldi, Graziella D'A. R. [1 ]
Pereira, Thales Dalessandro [2 ]
Fossaluza, Victor [2 ]
Nacif, Lucas [1 ]
Carneiro D'Albuquerque, Luiz Augusto [1 ]
Carrilho, Flair J.
Ono, Suzane Kioko [1 ]
机构：
[1] Univ Sao Paulo, Dept Gastroenterol, Sch Med, Sao Paulo, Brazil
[2] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, Brazil
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4211
引用
收藏
页码：S1281 / S1282
页数：2
相关论文
共 50 条
  • [31] Influence of CYP3A5 and ABCB1 Genetic Polymorphisms on Tacrolimus Dose Requirements in Recipients Following Liver Transplantation
    Li, Li
    Liu, Yu Qi
    Li, Yan Xiao
    Chen, Gang
    Zhao, Peng Ying
    LIVER TRANSPLANTATION, 2012, 18 : S88 - S88
  • [32] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [33] Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant
    Almeida-Paulo, G. N.
    Dapia Garcia, I.
    Lubomirov, R.
    Borobia, A. M.
    Alonso-Sanchez, N. L.
    Espinosa, L.
    Carcas-Sansuan, A. J.
    PHARMACOGENOMICS JOURNAL, 2018, 18 (01): : 180 - 186
  • [34] Frequency of common variants of ABCB1, CYP3A4 and CYP3A5 genes in Chilean subjects with primary hypercholesteromia
    Rosales, A.
    Pacheco, A.
    Saavedra, N.
    Lanas, F.
    Salazar, L. A.
    CIRCULATION, 2008, 118 (12) : E273 - E274
  • [35] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Naushaed, Shaik Mohammad
    Payani, Addepalli
    Rupasree, Yedluri
    Hussain, Tajamul
    Alrokayan, Salman A.
    Kutala, Vijay Kumar
    PHARMACOLOGICAL REPORTS, 2019, 71 (03) : 385 - 392
  • [36] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Shaik Mohammad Naushad
    Addepalli Pavani
    Yedluri Rupasree
    Tajamul Hussain
    Salman A. Alrokayan
    Vijay Kumar Kutala
    Pharmacological Reports, 2019, 71 : 385 - 392
  • [37] Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients
    Yildirim, Engin
    Sahin, Garip
    Kaltus, Zuhal
    Colak, Ertugrul
    CLINICAL LABORATORY, 2019, 65 (11) : 2079 - 2089
  • [38] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
  • [39] Impact of CYP3A4, CYP3A5 and ABCB1 genotype and intestinal expression on the pharmacokinetics of budesonide
    Ufer, M.
    Dilger, K.
    Leschhorn, L.
    Daufresne, L. M.
    Mosyagin, I.
    Rosenstiel, P.
    Haesler, R.
    Nikolaus, S.
    Schreiber, S.
    Cascorbi, I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 379 - 379
  • [40] Early clinical relevance of donor/recipient CYP3A5, CYP3A4 and ABCB1 polymorphisms after liver transplantation under tacrolimus immunosuppression
    Argudo-Ramirez, A.
    Gonzalez De Aledo, J. M.
    Ramirez, P.
    Castellote, J.
    Alia-Ramos, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S641 - S641
12345